Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06263647 · ClinicalTrials.gov registry record · NA
Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence
A NA study of Firearm Injury, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 274
- Enrollment target
- 1
- Study location
NCT06263647: Recruiting NA study of Firearm Injury, sponsored by The University of Texas Health Science Center, Houston.
NCT06263647 is a NA study of Firearm Injury that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 274 participants, below the 5,444-participant average among 12 other Firearm Injury trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06263647, a NA study of Firearm Injury, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
- 1
- Study location
Study Summary
A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Using a randomized controlled trial, the study will assess the effectiveness of Houston-HVIP in reducing violent reinjury and improving behavioral, mental, and physical health outcomes over a 12-month follow-up period among those enrolled in the study in ages 16-35 years of age.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Houston-HVIP treatment
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2025-09-16 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT06263647 shows while recruiting
NCT06263647 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, below the 5,444-participant average among 12 other Firearm Injury trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Firearm Injury appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06263647 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06263647 about?
NCT06263647 is a clinical study titled "Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence". A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Using a ran...
What is the current status of trial NCT06263647?
This trial is currently recruiting. It is a NA study. The enrollment target is 274 participants. The study started on 2025-09-16. Estimated completion is 2028-05-31.
What conditions does trial NCT06263647 study?
This clinical trial studies the following conditions: Firearm Injury.
What interventions are being tested in trial NCT06263647?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Houston-HVIP treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06263647?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06263647 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Firearm Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06263647's enrollment target sits among peer trials
274 6th of 12 higher than 7 of 12 other Firearm Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Firearm Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Target Safety: a Collaboration of Firearm Retailers and Health Care to Address Suicide Prevention
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
RECRUITING · NA
-
Safer Storage Safer Homes An Inpatient Pediatric Lethal Means Counseling Pilot Trial
RECRUITING · NA
-
Store Safely: Rural Firearm Injury Prevention for Families
RECRUITING · NA
-
Recovery Legal Care Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI